Cost-Effectiveness of ramucirumab plus paclitaxel as a...

PLoS ONE 2020 / 5 Vol. 15; Iss. 5

Cost-Effectiveness of ramucirumab plus paclitaxel as a second-line therapy for advanced gastric or gastro-oesophageal cancer in China

Li, Sini, Peng, Liubao, Tan, Chongqing, Zeng, Xiaohui, Wan, Xiaomin, Luo, Xia, Yi, Lidan, Li, Jianhe, De Mello, Ramon Andrade
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0232240
Date:
May, 2020
File:
PDF, 891 KB
2020
Conversion to is in progress
Conversion to is failed